Name : Sankush

(47Y/M)
Date : 02 Aug
2024
Test Asked : Aarogyam C Pro With
Utsh
Report Status: Complete
Report
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : SANKUSH (47Y/M) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC
: SELF
TEST 2 ROHINI,110085
ASKED : AAROGYAM C PRO WITH UTSH

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) 3.2 mg/L <3
TRIG / HDL RATIO 7.34 Ratio < 3.12
COMPLETE HEMOGRAM
BASOPHILS - ABSOLUTE COUNT 0.11 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT 0.66 X 10³ / µL 0.02 - 0.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 46.7 fL 39-46
TOTAL LEUCOCYTES COUNT (WBC) 10.96 X 10³ / µL 4.0 - 10.0
LIPID
HDL / LDL RATIO 0.27 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 33 mg/dL 40-60
LDL / HDL RATIO 3.6 Ratio 1.5-3.5
LDL CHOLESTEROL - DIRECT 120 mg/dL < 100
TC/ HDL CHOLESTEROL RATIO 5.5 Ratio 3-5
TRIGLYCERIDES 242 mg/dL < 150
VLDL CHOLESTEROL 48.42 mg/dL 5 - 40
LIVER
ALANINE TRANSAMINASE (SGPT) 72.6 U/L < 45
RENAL
CALCIUM 8.74 mg/dL 8.8-10.6
VITAMIN
25-OH VITAMIN D (TOTAL) 21.9 ng/mL 30-100

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed
report values, parameter correlation and clinical interpretation, kindly refer to the same in subsequent
pages.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST ASKED
: HBA PROFILE,HEMOGRAM

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 5.2 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory
Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 103 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl :
Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.

Sample Collected on (SCT)

: 02 Aug 2024 12:30
Sample Received on (SRT)
: 02 Aug 2024 16:38
Report Released on (RRT)
: 02 Aug 2024 18:02
Sample Type
Labcode : EDTA Whole Blood Dr Saakshi Mittal
MD(Path)
Barcode : 0208089987/DEL46
Page : 1 of
: CK584837 12
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : HBA PROFILE,HEMOGRAM

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL LEUCOCYTES COUNT (WBC) 10.96 X 10³ / µL 4.0 - 10.0

HF & FC
NEUTROPHILS Flow Cytometry 63.3 % 40-80
LYMPHOCYTE Flow Cytometry 22.7 % 20-40
MONOCYTES Flow Cytometry 6.8 % 2-10
EOSINOPHILS Flow Cytometry 6 % 1-6
BASOPHILS Flow Cytometry 1 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0-0.5
Flow Cytometry

NEUTROPHILS - ABSOLUTE COUNT 6.94 X 10³ / µL 2.0-7.0

Calculated

LYMPHOCYTES - ABSOLUTE COUNT 2.49 X 10³ / µL 1.0-3.0

Calculated

MONOCYTES - ABSOLUTE COUNT 0.75 X 10³ / µL 0.2 - 1.0

Calculated

BASOPHILS - ABSOLUTE COUNT 0.11 X 10³ / µL 0.02 - 0.1

Calculated
EOSINOPHILS - ABSOLUTE COUNT 0.66 X 10³ / µL 0.02 - 0.5
Calculated

IMMATURE GRANULOCYTES(IG) 0.02 X 10³ / µL 0-0.3

Calculated

TOTAL RBC 5.14 X 10^6/µL 4.5-5.5

HF & EI

NUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL 0.0-0.5

Calculated

NUCLEATED RED BLOOD CELLS % 0.01 % 0.0-5.0

Flow Cytometry
HEMOGLOBIN SLS-Hemoglobin Method 15.4 g/dL 13.0-17.0
HEMATOCRIT(PCV) 47.8 % 40.0-50.0
CPH Detection

MEAN CORPUSCULAR VOLUME(MCV) 93 fL 83.0-101.0

Calculated

MEAN CORPUSCULAR HEMOGLOBIN(MCH) 30 pq 27.0-32.0

Calculated

MEAN CORP.HEMO.CONC(MCHC) 32.2 g/dL 31.5-34.5

Calculated

RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) Calculated 46.7 fL 39-46

RED CELL DISTRIBUTION WIDTH (RDW-CV) 13.7 % 11.6-14

Calculated
PLATELET DISTRIBUTION WIDTH(PDW) 11.9 fL 9.6-15.2
Calculated
MEAN PLATELET VOLUME(MPV) 10.4 fL 6.5-12
Calculated
PLATELET COUNTPredominantly normocytic normochromic with 263 X 10³ / µL 150-410
Remarks : Alert!!! HF &ovalocytes.
EI Platelets:Appear adequate in smear.
PLATELET TO LARGE CELL RATIO(PLCR) 27.5 % 19.7-42.4
Calculated
Clinical history is asked for all the relevant abnormalities detected and in absence / failure of receiving of clinical history,
results are rechecked twice and released. Advised clinical
PLATELETCRIT(PCT) correlation. 0.27 % 0.19-0.39
Calculated
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse
height)

Sample Collected on (SCT) : 02 Aug 2024 12:30

Sample Received on (SRT) : 02 Aug 2024 16:38
Report Released on (RRT) : 02 Aug 2024 18:02
Sample Type : EDTA Whole Blood
Labcode Dr Saakshi Mittal
: 0208089987/DEL46
MD(Path)
Page : 2 of
: CK584837
Barcode 12
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST ASKED
: AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 21.9 ng/mL

Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are
critical for building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic
syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay
VITAMIN B-12 E.C.L.I.A 363 pg/mL
Bio. Ref. Interval. :
Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat,
eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin
sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic
anemias. For diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical
examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Please correlate with clinical conditions.

Sample Collected on (SCT)

: 02 Aug 2024 12:30
Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
: 02 Aug 2024 21:12
Sample Type
Labcode : SERUM Dr Saakshi Mittal
MD(Path)
Barcode : 0208098662/DEL46
Page : 3 of
: CK170320 12
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : SANKUSH (47Y/M) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 3.2 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

1. Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2. Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT)

: 02 Aug 2024 12:30
Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
Sample Type : 02 Aug 2024 21:12
Labcode
: SERUM
Page : 4 of
Dr Saakshi Mittal MD(Path)
: 0208098662/DEL46 12
Barcode

: CK170320
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : SANKUSH (47Y/M) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS

TESTOSTERONE E.C.L.I.A 450 ng/dL
Bio. Ref. Interval. :-

280 - 800

Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal
males. Major causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure
Hyperprolactinema, Hypopituitarism some types of liver and kidney diseases and critical illness.

Specifications: Precision: Intra assay (%CV): 11.50 %, Inter assay (%CV): 5.70%; Sensitivity: 7 ng/dL.
Kit Validation Reference: Wilson JD Foster DW (Eds) Williams Textbook of Endocrinology 8th Edition WB Saunders Piladelphia
Pennsylvania.

Note : The Biological Reference Range mentioned is specific to the age group and gender. Kindly correlate clinically.

Please correlate with clinical conditions.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT)

: 02 Aug 2024 12:30
Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
Sample Type : 02 Aug 2024 21:12
Labcode
: SERUM
Page : 5 of
Dr Saakshi Mittal MD(Path)
: 0208098662/DEL46 12
Barcode

: CK170320
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST ASKED
: AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 95.6 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 364.72 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : Spectrophotometric Assay
% TRANSFERRIN SATURATION CALCULATED 26.21 %
Bio. Ref. Interval. :
13 - 45
Method : Derived from IRON and TIBC values
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 269.12 µg/dL
Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY
Please correlate with clinical conditions.

Sample Collected on (SCT)

: 02 Aug 2024 12:30
Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
: 02 Aug 2024 21:12
Sample Type
Labcode : SERUM Dr Saakshi Mittal
MD(Path)
Barcode : 0208098662/DEL46
Page : 6 of
: CK170320 12
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 183 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 33 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.27 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 120 mg/dL < 100
TRIG / HDL RATIO CALCULATED 7.34 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 242 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 5.5 Ratio 3-5
LDL / HDL RATIO CALCULATED 3.6 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 150.3 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 48.42 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
HD/LD - Derived from HDL and LDL values.
LDL - Direct Measure
TRI/H - Derived from TRIG and HDL Values
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
LDL/ - Derived from serum HDL and LDL Values
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:

TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190

Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might
fluctuate.

Sample Collected on (SCT) : 02 Aug 2024 12:30

Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
: 02 Aug 2024 21:12
Sample Type
: SERUM Dr Saakshi Mittal
Labcode
MD(Path)
Barcode : 0208098662/DEL46
Page : 7 of
12
: CK170320
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 96.4 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 1.09 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.22 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.87 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 39.4 U/L < 55
SGOT / SGPT RATIO CALCULATED 0.4 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 28.8 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 72.6 U/L < 45
PROTEIN - TOTAL PHOTOMETRY 7.03 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.11 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.92 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.41 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 02 Aug 2024 12:30

Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
: 02 Aug 2024 21:12
Sample Type
: SERUM Dr Saakshi Mittal
Labcode
MD(Path)
Barcode : 0208098662/DEL46
Page : 8 of
12
: CK170320
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

UREA (CALCULATED) CALCULATED 18.83 mg/dL Adult : 17-43
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.8 mg/dL 7.94 - 20.07
UREA / SR.CREATININE RATIO CALCULATED 22.69 Ratio < 52
CREATININE - SERUM PHOTOMETRY 0.83 mg/dL 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 10.6 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 8.74 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.97 mg/dL 4.2 - 7.3
SODIUM I.S.E 140 mmol/L 136 - 145
CHLORIDE I.S.E 103 mmol/L 98 - 107
Please correlate with clinical conditions.

Method :
UREAC - Derived from BUN Value.
BUN - Kinetic UV Assay.
UR/CR - Derived from UREA and Sr.Creatinine values.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
SOD - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

Sample Collected on (SCT) : 02 Aug 2024 12:30

Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
: 02 Aug 2024 21:12
Sample Type
: SERUM Dr Saakshi Mittal
Labcode
MD(Path)
Barcode : 0208098662/DEL46
Page : 9 of
12
: CK170320
 PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: SANKUSH (47Y/M)
(212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
REF. BY ROHINI,110085
: SELF
TEST ASKED
: AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 148 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 7.68 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 1.44 µIU/mL 0.54-5.30

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate
clinically. Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT)

: 02 Aug 2024 12:30
Sample Received on (SRT)
Report Released on (RRT) : 02 Aug 2024 19:34

Sample Type : 02 Aug 2024 21:12

Labcode : SERUM Dr Saakshi Mittal

Barcode MD(Path) Page : 10 of
: 0208098662/DEL46
12
: CK170320
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : SANKUSH (47Y/M) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 112 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to
routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report
the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured
easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy
to interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine
Equation

~~ End of report ~~

Sample Collected on (SCT)

: 02 Aug 2024 12:30
Sample Received on (SRT)
: 02 Aug 2024 19:34
Report Released on (RRT)
Sample Type : 02 Aug 2024 21:12
Labcode
: SERUM
Page : 11 of
Dr Saakshi Mittal MD(Path)
: 0208098662/DEL46 12
Barcode

: CK170320
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical
treatment. v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333

+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 12 of 12